fluorodeoxyglucose f18 has been researched along with metyrapone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bankstahl, JP; Bascuñana, P; Delgado, M; Fernández de la Rosa, R; García-García, L; Gomez, F; Pozo, MA; Shiha, AA; Silván, Á | 1 |
| Hirota, S; Kadoya, M; Koyama, H; Kurajoh, M; Miyoshi, A; Moriwaki, Y; Nakamoto, Y; Shoji, T; Terada, T; Tsukamoto, Y | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and metyrapone
| Article | Year |
|---|---|
Metyrapone prevents brain damage induced by status epilepticus in the rat lithium-pilocarpine model.
Topics: Animals; Astrocytes; Autoradiography; Brain; Carbazoles; Carrier Proteins; Disease Models, Animal; Enzyme Inhibitors; Fluorodeoxyglucose F18; Gliosis; Glucose; Immunohistochemistry; Lithium Compounds; Male; Metyrapone; Neuroprotective Agents; Pilocarpine; Positron-Emission Tomography; Radiopharmaceuticals; Rats, Sprague-Dawley; Receptors, GABA-A; Status Epilepticus | 2017 |
Ectopic adrenocorticotropic hormone syndrome associated with olfactory neuroblastoma: acquirement of adrenocorticotropic hormone expression during disease course as shown by serial immunohistochemistry examinations.
Topics: Adrenocorticotropic Hormone; Blood Glucose; Disease Progression; Eosinophils; Esthesioneuroblastoma, Olfactory; Fluorodeoxyglucose F18; Humans; Hydrocortisone; Immunohistochemistry; Leukocyte Count; Male; Metyrapone; Middle Aged; Octreotide; Positron-Emission Tomography; Potassium; Syndrome | 2018 |